Prospeo
Hero Section BackgroundHero Section Background
Numab Therapeutics

Numab Therapeutics Revenue

Biotechnology ResearchFlag of CHHorgen, Zurich, Switzerland51-100 Employees

$

Numab Therapeutics revenue & valuation

Annual revenue$16,600,000
Revenue per employee$238,000
Estimated valuation?$53,200,000
Total funding$54,900,000

Key Contacts at Numab Therapeutics

Flag of CH

Josie Adams

Associate Director Clinical Operations

Flag of CH

David Urech

Ceo

Flag of CH

Aljaz Zajc

Senior Director - Head Controlling

Flag of CH

Venkat Raman Ramnarayan

Associate Director Antibody Discovery

Flag of CH

Fabio Spiga

Associate Director - Group Leader Spr & Ligand Binding

Flag of CH

Dario Zimmerli

Associate Director

Flag of CH

Nathalie Steinhoff

Associate Director, Group Leader Pharm/Tox

Flag of CH

Monika Kijanska

Director Project Leader R&D

Flag of CH

Marta Trueb

Associate Director And Group Leader

Flag of CH

Christopher Weinert

Associate Director – Formulation & Analytics

Company overview

HeadquartersBachtobelstrasse 5, Horgen, 8810, CH
Phone number+41445330471
Website
NAICS541714
SIC382
Founded2011
Employees51-100
Socials

Numab Therapeutics Email Formats

Numab Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@numab.com), used 52.7% of the time.

FormatExamplePercentage
{first name}.{last name}
john.doe@numab.com
52.7%
{first initial}.{last name}
j.doe@numab.com
47.3%

About Numab Therapeutics

Numab Therapeutics is developing multi-specific antibody-based immunotherapies for inflammation and cancer. Reproducible plug-and-play therapeutic design process using proprietary platforms λ-Cap™ and MATCH™ puts Numab in a unique position to overcome historical drug discovery barriers and build a pipeline of first-in-class and best-in-class medicines aimed to maximize patient benefits. Our lead candidate NM26, a unique multi-specific targeting IL-4/13 and IL-31 for best-in-class efficacy, is developed with a vision of delivering a lifelong cure to patients suffering from atopic dermatitis (AD) and other potential indications.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry
Director
C-Suite

Employees by Department

Numab Therapeutics has 37 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Numab Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-01-056N/A
2025-02-096$54,900,000

Funding Insights

$54,900,000

Total funding amount

$54,900,000

Most recent funding amount

2

Number of funding rounds

Numab Therapeutics Tech Stack

Discover the technologies and tools that power Numab Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

Cloudflare

CDN

Modernizr

Modernizr

JavaScript libraries

Apache HTTP Server

Apache HTTP Server

Web servers

reCAPTCHA

reCAPTCHA

Security

jQuery

jQuery

JavaScript libraries

Constant Contact

Constant Contact

Email

Underscore.js

Underscore.js

JavaScript libraries

Google Tag Manager

Google Tag Manager

Tag managers

PHP

PHP

Programming languages

HSTS

HSTS

Security

Open Graph

Open Graph

Miscellaneous

WordPress

WordPress

Blogs

Frequently asked questions

Numab Therapeutics is located in Horgen, Zurich, CH.
You can reach Numab Therapeutics at +41445330471.
Numab Therapeutics generates an estimated annual revenue of $16,599,999. This revenue figure reflects the company's market position and business performance in its industry.
Numab Therapeutics has an estimated valuation of $53,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Numab Therapeutics was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.
Numab Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.
Numab Therapeutics has raised a total of $54,900,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles